Integrating Novel Therapies for NET Tumors: How to Make the Right Choices will be presented by the Roswell Park Cancer Institute on Saturday, October 29. Join neuroendocrine tumor (NET) patients and caregivers for a day of networking and information sharing. Experts from Roswell Park will cover topics such as genetics of NETs, diagnosis and follow-up, hormonal therapies, role of peptide receptor radionuclide therapy (PRRT) in the treatment of NETs,  and clinical trials. Questions are encouraged! There is no charge to attend.

Click here for a complete agenda.

Click here to register.

For further information contact the Roswell Park Cancer Insitute at 1-877-275-7724.